Media / Intelligence
Prism Communications provides accurate and sophisticated media monitoring service to our clients. We provide not only brief and concise synopsis translations, but also insightful intelligence. Intelligence reports contain helpful information, which gives our clients an opportunity to better understand the current situation as well as background information.
With more than 20 years' experience in marketing and communications in Korea, Heesang Yoo, Managing Consultant of Prism Communications, has a great relationship with publications and journalists in Korea, as well as with the international media and correspondents.
Prism Communications can provide the very best media relations to potential clients.
Brand/Corporate Image Launches
Prism Communications has successfully launched some of the most important and precious brands and corporates in Korea in the areas of technology, telecommunications, finance, healthcare, FMCG, and lifestyle. Brand ad corporates include Microsoft, Intel, MSD, Eli Lilly, Barclays, Diageo, P&G, Unilever, and Pfizer.
Feature/Byline Article Placements
Issues /Crisis Managements
Identifying, mapping, and engaging major stakeholders are important aspects in marketing and communications in Korea. Prism Communications is one of the best at providing service in these areas with professionals serving in this industry for more 40 years combined.
Storytelling is still one of the most important aspects of public relations. Prism Communications can provide tailored feature articles and byline article placement in Korea.
Prism Communications provides point-to-point services, including research potential story angles, development of content, identification of target media, and, finally, securing space and placement.
With in-depth knowledge and experience, including legal issues, government-relevant issues, product issues, and labor issues, we provide tailored services that meets our clients' needs. Our experience has been mostly with large companies, like Microsoft, Intel, Pfizer, Eli Lilly, Barclays, Lockheed Martin, and EDS.